SEC Form 4 · accession 0001179110-15-009609
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tibor Keler
Officer — Executive VP & CSO
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 3:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionF1 | $25.41 | Jun 10, 2015 | A | 116,500 | A | Jun 10, 2016 | Jun 10, 2025 | Common Stock | 116,500 | 116,500 | D |
Explanation of responses
- F125% vest on June 10, 2016 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.